Literature DB >> 9100577

Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone.

M Behr1, D B Ramsden, U Loos.   

Abstract

We describe the analysis of a thyroid hormone receptor (TR) beta causing resistance to thyroid hormone, the patient exhibiting hypothyroid symptoms (severe mental retardation, hypoactivity, obesity) and hyperthyroid symptoms (tachycardia, low serum cholesterol) and, additionally, relative early puberty, advanced bone age, and short stature. The patient was heterozygous, with a point mutation producing a premature stop-codon in TR beta-gene exon 10, resulting in a 28-amino acid carboxy-terminal deletion in the cognate TR beta (TR beta-EZ). T3 binding was abolished. Homodimer binding of TR beta-EZ to DR4- and F2-T3 response elements (TREs) was weaker, and to a palindromic TRE (PAL) was stronger than that of wild-type TR beta (TR beta-WT) in the absence of T3. T3 dissociated TR beta-WT, but not TR beta-EZ homodimer, from DR4, F2, and Pal. Heterodimerization of TR beta-EZ with retinoid x receptor beta was seen. TR beta-EZ repressed basal thymidine kinase-promotor activity, coupled to DR4, F2, or PAL. Silencing of basal gene transcription via PAL was weaker, and via DR4 and F2 was more pronounced, compared with TR beta-WT. TR beta-EZ had a strong dominant negative effect on TR beta-WT, attenuated in a TRE- and cell-specific manner by high T3 concentrations. Finally, the degree of TR beta-EZ homodimer-binding affinity to DNA did not correlate with the degree of transcriptional dominant negative activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9100577     DOI: 10.1210/jcem.82.4.3853

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Call for action: preventing and managing the expansive and expensive obesity epidemic.

Authors:  D C Lau
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

2.  Pathogenic mechanism of mutations in the thyroid hormone receptor β gene.

Authors:  S Pongjantarasatian; S Wacharasindhu; S Tongkobpetch; K Suphapeetiporn; V Shotelersuk
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

3.  Cloning of a functional promoter of the human sodium/iodide-symporter gene.

Authors:  M Behr; T L Schmitt; C R Espinoza; U Loos
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

Review 4.  Mutational Landscape of Resistance to Thyroid Hormone Beta (RTHβ).

Authors:  Paola Concolino; Alessandra Costella; Rosa Maria Paragliola
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

Review 5.  Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.

Authors:  J H Duncan Bassett; Graham R Williams
Journal:  Endocr Rev       Date:  2016-02-10       Impact factor: 19.871

Review 6.  How obesity develops: insights from the new biology.

Authors:  D York; C Bouchard
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.